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Original Article
Infective endocarditis in patients with congenitally
malformed hearts: characterization of the syndrome
in a developing country
Bilal K. Siddiqui, Muhammed Tariq, Atif Jadoon, Ghulam Murtaza, Asim Syed, M. Bilal Abid,
Maria Qamaruddin, Mehnaz Atiq, Raymond A. Smego
Department of Medicine, Aga Khan University, Karachi, Pakistan
Abstract Objective: Cardiac surgery for correction or palliation of congenital cardiac disease in infancy and
childhood remains a privilege that is rarely accessible to two-thirds of the world’s population. This imbalance has
created a unique spectrum of illness in patients with underlying congenital cardiac disease and complicating
infective endocarditis in developing countries, including Pakistan. In this study, we characterize endocarditis as
seen in such patients presenting in Karachi. Patients and settings: We reviewed retrospectively patients admitted
to Aga Khan University with underlying congenitally malformed hearts and endocarditis between 1991 and
2004. Results: We identified 48 patients with endocarditis according to the modified Duke Criterions, with just
over half the cases (54%) classified as definite endocarditis. Of the patients, 23 (49%) patients were more than 16
years old. Uncorrected left-to-right-shunts, tetralogy of Fallot, and congenital mitral valvar disease were the
most common underlying defects. Patients with cyanotic defects, particularly of the complex type, were
underrepresented (4%). Only 11 (22.9%) of the patients had a previous palliative or corrective surgery. In one-
third of the patients (16), streptococcal species were identified as the microbiologic cause of endocarditis, and 22
(45.8%) had culture-negative endocarditis. In contrast, Staphylococcus aureus and enterococci caused endocarditis
in only one patient each. There were no differences in mortality or complications between cyanotic and acyanotic
congenital defects. Surgery was performed in nine (18.7%) patients with endocarditis, and of these, 13 (27.1%)
died. Conclusions: In contrast to the developed world, endocarditis in the developing countries, such as Pakistan,
complicates uncorrected left-to-right shunts and tetralogy of Fallot, probably because patients with complex
cyanotic defects fail to survive long after birth due to the lack of available surgery. Almost half of patients had
culture-negative endocarditis, likely related to several factors.
Keywords: Endocarditis; cyanotic heart defects; acyanotic heart defects; uncorrected congenital heart disease
Introduction
The prevalence of cardiac malformations is approxi-
mately 8 per 1000 live births worldwide.1 The
success of cardiac surgery in the developed world
during the last two decades is enormous. A majority
of these patients undergoes surgery, with good or
satisfying long-term outcomes. With the advent of
modern cardiac surgery, even complex forms of
congenital cardiac disease may be corrected by a
definite or palliative operation. As a number of
these patients continue to survive into adolescence
and adulthood, congenital defects have become
one of the major predisposing factors for infective
endocarditis.2 In a nation-wide epidemiological
study on endocarditis from Netherlands, the under-
lying predisposition in about one-tenth of patients
was a congenitally malformed heart.3 Another study
of underlying cardiac lesions in adults with endo-
carditis demonstrated that 13% had congenital cardiac
disease.4 This association between congenitally
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malformed hearts and endocarditis remains a life-
threatening handicap for such individuals.
The luxury of early cardiac interventions for
congenital cardiac disease in infancy and childhood,
nonetheless, remains a privilege that is rarely
accessible to those residing in the developing world,
accounting for two-thirds of the global population.
As a result, many infants with complex defects in
developing countries do not see their first birthday.
Furthermore, cardiac defects in which the risk of
endocarditis could be significantly decreased with
corrective surgery, such as ventricular septal defects
and persistent patency of the arterial duct, are not
submitted for surgical correction. These defects are
generally compatible with survival into adolescence,
and thus form a large proportion of endocarditis in
the setting of congenital cardiac disease in devel-
oping countries such as Pakistan. Infective endo-
carditis in this subset of the population with
congenitally malformed hearts, to the best of our
knowledge, has not previously been studied from
countries in the developing world. In this case-
series, we study specifically endocarditis in patients
with congenitally malformed hearts, delineating the
underlying predisposing factors, epidemiology,
clinical presentation, complications and outcomes
in order better to define this clinical entity in a
region of the developing world.
Patients and methods
We reviewed retrospectively the medical records of
all patients admitted to Aga Khan University
Hospital, Karachi, Pakistan with underlying con-
genitally malformed hearts and a diagnosis of
endocarditis over a period from January, 1991, to
December, 2004. The hospital is located in the
center of Karachi, a multiethnic city with a popula-
tion of 15 million, representing all the ethnic
subgroups in Pakistan. The population includes a
large number of immigrants and referrals from
underserved rural areas, where undetected congeni-
tal cardiac disease is more common. The median
number of admissions during the period was 13,300
patients annually. In this study, we used the revised
Duke criterions for the diagnosis of endocarditis to
validate our results.5 Electronically coded medi-
cal records, and the echocardiographic logbook,
revealed 188 patients with suspected endocarditis.
Of these, 159 patients fulfilled the modified
criterions,5 and 48 of these (30.1%) had an
underlying congenitally malformed heart.
Many of the patients had a known congenital
defect, while others were diagnosed with congenital
cardiac disease after initially presenting with
endocarditis. Adults with congenital heart disease
were defined as those more than 16 years of age.
Fever was defined as a single reading of 388C or
more. Patients were classified to have acute endo-
carditis if they had symptoms for 10 days or less.
The number, site, size, and mobility of vegetations,
the site and importance of valvar regurgitation,
and other valvar injuries such as perforation, abscess,
aneurysm, or rupture of tendinous cords, were
detailed by transthoracic and transoesophageal
echocardiography. Vegetations were defined as
localized oscillating masses of dense shaggy echoes
that were attached to a valvar leaflet, or to a
supporting structure, or in the path of a turbulent
jet or on implanted material. A perivalvar abscess
was defined as a region of reduced echodensity or
echolucent cavity adjacent to the valve or within
the valvar annulus. A distinct region of reduced
echo density of greater than 5mm size inside the
ventricular myocardium, detectable throughout the
cardiac cycle, was regarded as an intramyocardial
abscess. Renal failure was defined by level of
creatinine in the serum greater than 2-mg/dl, or a
rise over baseline of greater than 1mg/dl in patients
with chronic renal insufficiency. Nosocomial en-
docarditis was identified if the patient developed
symptoms after 3 or more days of hospitalization for
reasons other than endocarditis.
The laboratory workup of these patients included
a complete blood count, erythrocytic sedimentation
rate, serum creatinine, serum electrolytes, urine
analysis and culture, chest X-ray, several blood
cultures, with 3 to 5 sets of aerobic and anaerobic
bottles inoculated in sterile Bactec PlusTM bottles
(Becton-Dickinson, NJ, USA) drawn before the
initiation of antibiotics, transthoracic echocardio-
graphy, and if needed, transoesophageal echocardio-
graphy. In patients with fever and headache or with
neurological signs, examination of cerebrospinal
fluids and appropriate imaging were conducted.
Fungal cultures were sent in selected cases. The
serological tests for Coxiella burnetii, Brucella, and
Bartonella were not sent because of financial
constraints of the patients and the low clinical index
of suspicion. Pakistan is not in the endemic zone
for these fastidious organisms, as only a few isolated
cases have been reported from northwest of the
country.6–8
Statistical interpretation of data was performed
using the computerized software program SPSS version
13.0 (SPSS, Inc, Chicago, IL, 1999). Descriptive
statistics are presented as percentages for discrete
variables. Continuous variables are presented as
mean plus or minus standard deviations.
Univariate analysis was done for factors associated
with mortality and to compare cyanotic and
acyanotic heart disease using Pearson Chi Square,
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Fischer Exact Test and Student’s t Test where
appropriate, and a p value of less than 0.05 was
considered statistically significant.
Results
We found 48 patients with congenitally malformed
hearts to have endocarditis according to the
modified Duke Criterions5 (Table 1). A steady rise
in the number of cases was seen over the period of
study. Of the 48 patients, 38 (80%) presented in the
second half of the study, from 1999 through 2004.
Mean follow-up was two-years and two and a half
months, and one patient was lost to follow-up.
Antibiotics prior to presentation had been given to
23 patients (48%), including 2nd and 3rd gen-
eration cephalosporins (40%), pencillin (20%),
aminoglycosides (30%) and Amoxicillin in 10%. In
54% of the patient, the endocarditis was definitive
according to the Duke criterions.5 Rheumatic heart
disease was a concomitant diagnosis in 4 (8.4%)
patients. Table 2 gives the distribution of congeni-
tally malformed hearts. Only 11 (22.9%) patients
had undergone previous surgery. Patients with
cyanotic heart disease were more likely to have
positive cultures (78% versus 48.7%), and had a
higher incidence of renal failure (28% versus 8.3%)
and thrombocytopenia (60% versus 11.7%, p-value
0.03, 95% CI 1.4-89). There were no differences
Table 1. General characteristics.
Characteristic Value
Number of patients 48
Age in years (median6 Standard Deviation) 126 16.7
0–6 years 14 (29.2%)
7–12 years 11 (22.9%)
13–18 years 5 (10.4%)
18–30 years 8 (16.7%)
31 years and above 10 (20.8%)
Sex (male: female) 1.8:1 (30/18)
Definite endocarditis1 26 (54%)
Possible endocarditis1 22 (46%)
Nosocomial2 2 (4.1%)
Prosthetic valve endocarditis 1 (2.2%)
Culture negative endocarditis3 22 (45.8%)
Acute endocarditis4 7 (14.6%)
Durations of symptoms in days (median6 SD) 306 94
Follow-up in weeks (mean6 SD) 326 337
Predisposing factors
Down’s syndrome5 3 (6.3%)
Diabetes Mellitis 1 (2.2%)
Previous endocarditis 1 (2.2%)
Recent gastrointestinal or genitourinary
manipulation
3 (6.3%)
SD Standard deviation, 1Modified Duke’s criteria, 2. 72 hrs in
hospital for reasons other than endocarditis, 3At least 2 sets of
negative cultures and persistent negative cultures through out the
course of endocarditis, 4Symptoms of ,10 days duration, 5One
patient each had a ventricular septal defect, ASD and a patent
arterial duct.
Table 2. Underlying congenital defects.
Congenital heart disease n (%) ,2 years 2–16 years .16 years1
Cyanotic congenital heart disease 8 (16.7%) 2 6 1
Tetralogy of Fallot 6 (12.5%) 1 4 1
Transposition 2 (4.2%) 0 2 0
Acyanotic congenital heart disease 40 (83.3%) 6 12 21
Ventricular septal defect 15 (31.3%) 4 5 6
Bicuspid aortic valve 5 (10.4%) 0 0 5
Atrial septal defect 3 (6.3%) 0 1 2
Patency of arterial duct 2 (4.2%) 1 1 0
Coarctation of aorta 2 (4.2%) 1 0 1
Congenital mitral regurgitiation 2 (4.2%) 0 2 0
Patent oval foramen 2 (4.2%) 0 0 2
Cleft mitral valve 1 (1.1%) 0 1 0
Congenital mitral stenosis 1 (1.1%) 0 1 0
Supravalvar pulmonary stenosis 1 (1.2%) 1 0 0
Mitral valvar prolapse 2 (4.2%) 0 1 1
Others 4 (8.4%) 0 0 4
Previous surgical correction or palliation 11 (22.9%)
Ventricular septal defect repair 3/12 (25%)
Tetralogy of Fallot 2/6 (33%)
Transposition 2/2 (100%)
Coarctation of aorta 1/2 (50%)
Patent arterial duct 1/2 (50%)
Atrial septal defect 1/3 (33%)
Mean age at surgery 4.66 3.5 yrs
Surgery for ,2 yrs None
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between cyanotic and acyanotic defects in terms of
death, heart failure, surgery, and complications.
Table 3 lists the pertinent clinical and laboratory
findings. In one-third (16/48) of our patients, blood
cultures were positive for streptococci, while 22
(45.8%) patients had persistent negative cultures.
Table 4 lists the aetiological agents isolated from
these patients. Echocardiography was performed in
46 (95.8%) patients, transthoracic echocardiogra-
phy in 45 (93.8%), and transoesophageal echocar-
diography in 6 patients (12.5%). Transthoracic
echocardiogram was positive in 30 of 45, giving
a sensitivity of 67%, and transoesophageal echo-
cardiography was positive in 5/6, with a sensit-
ivity of 87%. The valves involved, and other
significant findings on echocardiography, are listed
in Table 4.
Most patients were treated with a beta-lactam or
vancomycin in combination with gentamicin,
depending on the sensitivities, for from 4 to
6 weeks. Surgery was performed in 9 (18.75%)
patients, of whom 3 (33%) died. These patients
died of sepsis, heart failure, and brain abscess,
respectively. None of the organisms were signifi-
cantly related to surgery. The indications for surgery
were heart failure refractory to medical treatment,
stroke or peripheral embolism, very large or mobile
vegetations, and endocarditis refractory to medical
treatment. Of all the patients, 13 (27.1%) died due
to endocarditis or one of its complications (Table 5).
Table 6 illustrates the factors associated with
mortality in these patients. There were no differ-
ences in mortality between patients with or without
congenitally malformed hearts.
Discussion
Our study, to the best of our knowledge, represents
one of the first case-series of endocarditis in patients
with congenitally malformed hearts from the devel-
oping world. Most of the patients had uncorrected
malformations, such as ventricular septal defect,
tetralogy of Fallot, atrial septal defect, persistent
patency of the arterial duct, congenital mitral valvar
disease, and aortic coarctation. In contrast, approxi-
mately 70% of children with endocarditis complicat-
ing congenital cardiac disease in the developed world
have had previous cardiac surgery, particularly
palliative shunt procedures and complex intracardiac
repairs.9,10 Nearly one-third to half of all these
defects are critical, requiring intervention in the first
year of life.11 With currently available modalities for
Table 3. Clinical manifestations and laboratory findings.
Number and percentage
of patients affected
Signs & symptoms
Fever 43 (89.6%)
Heart murmur 41 (85.4%)
Splenomegaly 9 (18.8%)
Stroke 4 (8.3%)
Seizures 4 (8.3%)
Systemic embolization 3 (6.3%)
Splinter haemorrhages 4 (8.4%)
Clubbing 13 (27.1%)
Peticheae 1 (2.1%)
Mycotic aneurysm 1 (2.1%)
Laboratory findings
Anaemia 23 (47.9%)
Leukocytosis 16 (33.3%)
Elevated ESR 16/28 (57%)
Haematuria 3 (6.3%)
ESR: erythrocyte sedimentation rate; SD: Standard deviation.
Table 4. Distribution of organisms recovered from blood
cultures and echocardiographic findings seen in patients.
Organism isolated n (%)
Streptococci 16 (33.3%)
Viridans 9 (18.8%)
Intermedius 1 (2.1%)
Mitus 1 (2.1%)
Others 5 (10.4%)
Staphylococci 5 (10.4%)
Aureus 1 (2.1%)
Coagulase negative 4 (8.4%)
Pseudomonal species 2 (4.2%)
Enterococci 1 (2.1%)
Enterobacter 1 (2.6%)
Serratia 1 (2.1%)
No growth1 22 (45.8%)
Location on echocardiography2
Aortic valve 11 (22.9%)
Ventricular septal defect 9 (18.9%)
Mitral valve 9 (18.9%)
Pulmonary valve 4 (8.4%)
Tricuspid valve 6 (12.5%)
Patent arterial duct 2 (4.2%%)
Atrial septal defect 1 (2.1%)
Coarctation of aorta 1 (2.1%)
Pulmonary arteries 1 (2.1%)
Normal 8 (16.8%)
Right-sided endocarditis 13 (27.1%)
Character
Vegetations 27 (56.3%)
Mobile vegetations 11 (22.9%)
Large vegetation3 9 (18.8%)
Valvar abscess 1 (2.1%)
Multiple valves/locations 5 (10.4%)
Regurgitation4
Aortic 11 (23%)
Mitral 9 (18.8%)
Tricuspid 12 (25.1%)
1At least 2 sets of negative cultures and persistent negative cultures
through out the course of endocarditis, 2Includes multiple
vegetation/abscesses,3Size.10mm, 4Moderate to severe
regurgitation.
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treatment, over three-quarters of infants born with
critical cardiac disease can survive beyond the first
year of life, and many can lead near-normal lives
thereafter. This privilege of early diagnosis and
timely management is restricted to children and
adolescents of the developed countries. The majority
of children born with congenitally malformed
hearts in developing countries do not get the
necessary care, resulting in a high morbidity and
mortality. Only one-fifth of the patients seen in our
study had undergone a previous cardiac repair or
palliation. Previous studies on endocarditis in
children from the developing world have shown
that less than one fifth of those with congenitally
malformed hearts have had a previous surgical repair
or palliation.12–17 Congenital cardiac diseases in
developing countries remain undiagnosed and
under-treated.18–21
Patients with cyanotic heart disease, particularly
of the complex type, were underrepresented in our
study. These patients usually do not survive without
surgery, while repair, insertion of prosthetic mater-
ial, or palliation leads to a very high annual risk
for endocarditis.22,23 Cyanotic heart defects as an
underlying predisposition for endocarditis in the
United States increased from less than 20% in
1950s to 45% by the 1970s.10 As a large majority
of patients with complex cyanotic heart disease
never survive to childhood, or even infancy, in most
of the developing world, these lesions constitute
only one-fifth or less of those with endocarditis and
congenital cardiac disease.12–17,24,25 Of those with
cyanotic diseases, tetralogy of Fallot constitutes
three-quarters of the patients in our series. The
other two patients with complex cyanotic heart
disease had transposition, and had undergone
surgical repair in infancy. This emphasizes the fact
that survival of patients with complex cyanotic
heart diseases without corrective surgery is dismal.
Tetralogy of Fallot represents an exception among
cyanotic heart diseases, as children with this
condition can survive several years without surgery.
In fact, some patients may go unrecognized till late
in infancy, and present with endocarditis in child-
hood. Only one-third of the patients with tetralogy
of Fallot in our series had undergone surgical
correction. Recent studies have shown that tetralogy
of Fallot is now a rare cause of endocarditis in both
children and adults in the developed world.26
Complete closure of the ventricular septal defect
associated with tetralogy of Fallot, eliminating
the systemic-to-pulmonary shunt, minimizes the
susceptibility to endocarditis.22,23
Left-to-right shunts, particularly in those with
uncorrected ventricular and atrial septal defects and
arterial ducts, are the most common underlying
defects seen in our series. This trend is similar to
the experience in the developed world prior to the
emergence of definitive surgery. High-velocity or
turbulent flow caused by the high pressure left-
sided circulation causes endocardial damage, and
creates a nidus for subsequent bacterial colonization
and endocarditis. Early detection and surgical repair
has lead to a decline in the importance of left-
to-right shunts as sites of bacterial endocarditis in
the developed world.9–11 Complete surgical repair
eliminates, or markedly decreases, the risk of
endocarditis in these patients.27 Of a large cohort
seen in a community-based 30-year study, none of
the patients with a definitively corrected ventricular
septal defect developed endocarditis.22 Without
surgical repair, nonetheless, these patients are at
high risk for endocarditis, with an incidence of
1.1% at 5 years of age or an overall risk of 3.8 cases
per 1000 patient-years.22 As a result ventricular
septal defect now constitutes less than one-fifth of
those with endocarditis in the developed world.9,10
On the other hand, ventricular septal defect is the
most common underlying congenital anomaly seen
in both adults and children in our series. Of these,
four-fifths had not undergone prior surgical correc-
tion. A similar trend is seen in the rest of the
developing world, where ventricular septal defect
accounts for almost half of congenital defects in
children with endocarditis,12–17,24,25 of whom only
5 to15% had undergone prior surgical repair.
Table 5. Complications and mortality observed in patients with
infective endocarditis.
Complications n (%)
Death 13 (27.1%)
Surgery needed 9 (18.8%)
Neurological complications 12 (25%)
Stroke 4 (8.3%)
Intracanial haemorrhage 2 (4.2%)
Seizures 4 (8.3%)
Meningitis 1 (2.1%)
Brain abscess 1 (2.1%)
Renal complications 5 (10.4%)
Renal failure1 5 (10.4%)
Glomerulonephritis 1 (2.1%)
Interstitial nephritis 1 (2.1%)
Hemolysis 4 (8.3%)
Cardiac
Heart failure 13 (27.1%)
Cardiac abscess 1 (2.1%)
Valvular insufficiency 21 (43.8%)
Peripheral embolism 3 (6.3%)
Mycotic aneurysm 1 (2.1%)
Pneumonia 5 (10.4%)
Sepsis 1 (2.1%)
1Defined as serum creatinine level .2mg/dl or a rise over baseline
creatinine of .1mg/dl in patients with chronic renal insufficiency.
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In 2 of our patients, infective endocarditis
developed in the setting of an underlying patent
arterial duct. A recent study from northern Pakistan
reported that infective endocarditis of patent arterial
duct might be very common.28 This high incidence
of infective endocarditis in patients with patent
arterial duct is unusual, and represents something
close to the natural history of uncorrected patent
arterial duct,29 as suture ligation of patent arterial
duct completely eliminates the risk of endocarditis.
Infective endarteritis of patent arterial duct is now
extremely rare in most parts of the world.9,11,30
More than one-tenth of our patients had a
bicuspid aortic valve. The natural history of
a bicuspid valve is premature calcification, which
occurs in nearly all individuals aged 40 years, with
subsequent possibility of progression to aortic
stenosis. Endocarditis is a well-recognized complica-
tion, usually occurring in the fourth and fifth
decades of life, as in our series. Most data from the
developed4,31 and developing world32 reports that
bicuspid aortic valve may be the underlying cause for
up to one-sixth of patients with native valvar
endocarditis. This entity is considered to be the most
common congenital cardiac lesion seen at autopsies.33
Neonates, infants and young children undergoing
palliative or corrective surgery currently represent
the largest group of children at risk of endocarditis
in most of the developed world. It should be
emphasized that the increase in overall incidence of
endocarditis is largely due to a greater frequency
of the disease among the neonates and children
under 2 years of age, as seen in our series. On the
other hand, our series also has a large proportion of
adults more than 16 years. As more patients with
these defects are reaching adulthood, the number of
cases of endocarditis in adults with congenitally
malformed hearts has increased.34
Boys outnumber girls in our series. This is in
contrast to most of the data worldwide, except
Table 6. Risk factors for mortality in patients with Infective endocarditis and congenital heart disease.
Variable Dead Alive p value CI at 95%
General characteristics
Age (mean6 SD) 22.56 18 16.76 16 NS1 0.5–16
Sex (male) 7 23 NS 0.17–2.2
Acute endocarditis 6 9 NS 0.63–9
Culture positive endocarditis 7 19 NS 0.27–3.5
Definitive endocarditis 6 20 NS 0.17–2.3
Nosocomial 2 0 0.062 2.5–7.0
Presentation
Fever 12 31 NS 0.15–15.2
Splenomegaly 2 7 NS2 0.13–4.6
Anemia 7 16 NS 0.39–5
Thrombocytopenia 1 6 NS2 0.045–4.05
Lekocytosis 4 12 NS2 0.21–3.3
Clubbing 6 7 NS 0.87–13.5
Predisposing factors
Cyanotic heart disease 3 6 NS2 0.3–6.9
Ventricular septal defect 2 13 NS2 0.05–1.6
Previous cardiac surgery 5 7 NS 0.62–10
Prosthetic valvar endocarditis 1 0 NS2 0.79–1.08
Microbiology
Streptococci 3 13 NS2 0.12–2.2
Pseudomonas spp. 2 0 0.062 2.5–7.0
Complications
Neurological complications 3 9 NS2 0.19–3.8
Renal failure3 2 3 NS2 0.29–13.2
Hemolysis 1 3 NS2 0.08–9.4
Peripheral embolism 1 2 NS2 0.085–13
Heart failure 9 4 ,0.0012 3.6–84
Large vegetation4 4 5 NS2 0.6–12
Mobile vegetation 3 8 NS2 0.223–4.6
Multiple valves 2 3 NS2 0.29–13.2
Pneumonia 3 2 NS2 0.72–34
Sepsis 1 0 NS2 0.79–108
Surgery for endocarditis 3 6 NS2 0.27–6.2
NS: Not Significant; SD: Standard deviation. 1Student’s t-test, 2Fischer Exact Test, 3Defined as serum creatinine level .2mg/dl or a rise over
baseline of .1mg/dl in patients with chronic renal insufficiency, 4Size.10mm.
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South Asia.24,25,33 This may be because of bias on
behalf of parents in South Asia to favour the male
child over the female. Males are better cared for, and
taken to the hospital more frequently for treatment.
On the other hand, many girls in South Asia with
life-threatening diseases, such as congenitally mal-
formed hearts, are generally left to the ‘‘will of God’’
to suffer a natural course of events, and never make
it to the hospital.
Both patients with nosocomial endocarditis in
our series died. Nosocomial endocarditis is usually
associated with a structurally normal heart, and
occurs in the setting of surgical procedures or use of
intravenous catheters.35 The high mortality in our
patients is consistent with worldwide data, where
nosocomial endocarditis carries a mortality of more
than half. In a recent series from Madrid, nosocomial
infection accounted for endocarditis in over one-fifth
of patients, and resulted in more than half dying.36
We see a lot of patients with endocarditis and
negative cultures. The high ratio of negative
cultures is not unusual for developing countries,
and has been found in up to three-fifths.24,25 The
most common important cause of such a high ratio
of culture-negative endocarditis is prior use of
antibiotics without appropriate workup, as seen in
half of our patients.
Mortality of endocarditis seen in our series is much
higher than most of the developed world, where it is
generally between 5 and 20%. We are a tertiary care
referral centre, and these results may represent a
skewed population. This high mortality can be
attributed to late presentation, prior use of anti-
biotics causing negative cultures with subsequent
late diagnosis, and advanced underlying cardiac
diseases such as severe pulmonary hypertension. It
is important to note that patients from developed
countries with endocarditis are already high risk
because of more complex congenital heart diseases.
Many of these children have already undergone
multiple cardiac surgeries before presentation, and
more frequently acquire nosocomial endocarditis,
which carries a grave prognosis. Despite these
predisposing factors for endocarditis in the developed
world, the comparatively higher mortality seen in
this series further emphasizes the need aggressively to
treat and prevent endocarditis in Pakistan.
Our study has several limitations. First, the
retrospective nature of the study does not allow for
control of data and requires cautious interpretation
of the results. Serology and polymerase chain
reaction for fastidious organisms such as Brucella,
Bartonella, Coxiella burnetii, and other rare causes
of endocarditis were not sent, and thus we may have
missed some patients with culture-negative endo-
carditis. Being a tertiary care private referral center,
the data may not truly represent endocarditis in the
community, and may be skewed towards a high-risk
patient and wealthier population. Our study was
not adequately powered to identify risk factors for
mortality because of the small size of the sample.
Many of the patients received prior antibiotics, and
thus the ‘true’ microbiology cannot be ascertained.
The series most likely underestimates the true
incidence of endocarditis, given the limitations in
microbiologic detection of the cause of endocarditis.
Further prospective studies are needed to confirm
our results.
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